Several publications have also shown a direct correlation between PTEN loss and an increased risk of biochemical recurrence following prostatectomy proving useful for categorising patients with PCa into different prognosis groups for targeted treatments (68, 69, 125, 127). This evidence concerns the gene PTEN and posterior cortical atrophy.